NCT00007033
- Conditions
- Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +18 more
- Locations
-
- Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States
Clinical trial condition
Cholestasis, Intrahepatic
Explore clinical trials studying Cholestasis, Intrahepatic. Study availability and eligibility vary by location and protocol.
169 public trials
37 recruiting studies
Cholestasis, Intrahepatic trial results
NCT00001642
- Conditions
- Abnormalities, Multiple, Alagille Syndrome, Aneuploidy, +17 more
- Locations
-
- National Human Genome Research Institute (NHGRI) Bethesda, Maryland, United States
NCT00490620
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- St Louis University St Louis, Missouri, United States
- University of Alberta Edmonton, Alberta, Canada
- University of Montreal Montreal, Quebec, Canada
Completed
Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
NCT00004784
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
- Locations
-
Not specified
NCT00004748
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
- Locations
-
Not specified
Active, Not Recruiting
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
NCT04526665
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
- Locations
-
- The Institute for Liver Health Chandler, Arizona, United States
- Keck Medical Center of USC Los Angeles, California, United States
- Ruane Clinical Research Group Inc. Los Angeles, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
Active, Not Recruiting
A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)
NCT06730061
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
- Locations
-
- Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
- Fukushima Medical University Hospital Fukushima, Japan
- Chugoku Rosai Hospital Hiroshima, Japan
- Teine Keijinkai Hospital Hokkaido, Japan
Active, Not Recruiting
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
NCT05035030
- Conditions
- Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +11 more
- Locations
-
- Rady Children's Hospital San Diego, California, United States
- UCSF San Francisco, California, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- Riley Hospital for Children at IU Health Indianapolis, Indiana, United States
NCT06247735
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
- Locations
-
- UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
- Southern California Research Center - Coronado Coronado, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Velocity Clinical Research Santa Ana, California, United States
Active, Not Recruiting
Linerixibat Long-term Safety, and Tolerability Study
NCT04167358
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
- Locations
-
- GSK Investigational Site Davis, California, United States
- GSK Investigational Site West Hollywood, California, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Detroit, Michigan, United States